Search results for "Mabs"
Article
What is process development?
What is process development?
Biopharma process development comprises the activities that help you create a series of steps to produce a biomolecule – a monoclonal antibody (mAb), recomb…
Article
Top Process Development Trends for 2022 and a Look into 2023
Mechanistic modeling is a mathematical representation of the physiochemical transport and interactions that occur during chromatography, and can be applied for mAbs process development, but also advan…
Article
Establishing a Robust Workflow to Identify High-Performing GOCHO™ Clones
Our cell line development platform uses the GOCHO™ host cell line to minimize the risk and timeline to develop high-performing clones suitable for manufacturing.
LEARN MORE >>
Article
Sign-up to join Chromatography Virtual Summit 2022
Latest advancements in chromatography process development.
Go smarter. Go faster.
Virtual event 15–17 November 2022
Join the Cytiva chromatography summit online to l…
Article
Approaches to scaling up Chromatography Processes
Scaling up chromatography resins requires a thorough understanding of their intended use.
READ FULL ARTICLE >>
Article
Optimization of an antibody polishing step
Antibody purification processes are typically developed using a platform approach. Optimal operating conditions for single units are found by altering just a few process parameters with De…
Article
Bispecific Antibodies are Moving from Research to Clinical Development
With recent approvals of bispecific antibodies, these complex molecules are fast moving out of the research box and into clinical pipelines.
READ MORE >>
Article
Navigating Molecular Diversity
Are you working with biomolecules beyond mAbs?
Read more here >>
Article
Getting Started with Fibro PrismA - Free e-Learning
Learn about Fibro PrismA >>
Are you using resin-based columns? Fibro PrismA units for rapid cycling chromatography connect to ÄKTA™ systems in the same way. Additionally, you can use the s…
Article
Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
The rise of therapeutic monoclonal antibodies (mAbs) in the 1980s drove the requirement to adapt Chinese hamster ovary (CHO) cells to suspension in order to allow the use of stirred tank bioreactor fo…